Outcomes according to BAALC and ERG expression in older CN-AML patients
| Outcome . | Low BAALC (n = 79) . | High BAALC (n = 79) . | P . | Low ERG (n = 79) . | High ERG (n = 79) . | P . |
|---|---|---|---|---|---|---|
| Complete remission rate, no. (%) | 68 (86) | 43 (54) | < .001 | 60 (76) | 51 (65) | .12 |
| Disease-free survival | .01 | .03 | ||||
| Median, y | 1.0 | 0.6 | 1.0 | 0.6 | ||
| Disease-free at 3 y, % (95% CI) | 19 (11-29) | 12 (4-23) | 18 (10-29) | 14 (6-25) | ||
| Overall survival | < .001 | .003 | ||||
| Median, y | 1.5 | 0.8 | 1.4 | 0.8 | ||
| Alive at 3 y, % (95% CI) | 29 (19-39) | 10 (5-18) | 24 (15-34) | 15 (8-24) |
| Outcome . | Low BAALC (n = 79) . | High BAALC (n = 79) . | P . | Low ERG (n = 79) . | High ERG (n = 79) . | P . |
|---|---|---|---|---|---|---|
| Complete remission rate, no. (%) | 68 (86) | 43 (54) | < .001 | 60 (76) | 51 (65) | .12 |
| Disease-free survival | .01 | .03 | ||||
| Median, y | 1.0 | 0.6 | 1.0 | 0.6 | ||
| Disease-free at 3 y, % (95% CI) | 19 (11-29) | 12 (4-23) | 18 (10-29) | 14 (6-25) | ||
| Overall survival | < .001 | .003 | ||||
| Median, y | 1.5 | 0.8 | 1.4 | 0.8 | ||
| Alive at 3 y, % (95% CI) | 29 (19-39) | 10 (5-18) | 24 (15-34) | 15 (8-24) |
CI indicates confidence interval.